Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- Author(s):
- Taylor, P.C.; Keystone, E.C.; Heijde, D. van der; Weinblatt, M.E.; Morales, L.D.; Gonzaga, J.R.; Yakushin, S.; Ishii, T.; Emoto, K.; Beattie, S.; Arora, V.; Gaich, C.; Rooney, T.; Schlichting, D.; Macias, W.L.; Bono, S. de; Tanaka, Y.
- Published
- 2017
- Publication type
- Article / Letter to editor
- Date issued
- 2017-02-16
- Language
- English
- Is part of
- New England Journal of Medicine (2017), Vol. 376, no. 7, p. 652-662
- hdl
- 1887/114283
- doi
- 10.1056/NEJMoa1608345